Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Vor Biopharma Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q1 2025
- Shares held
- 57.1M
- −3.06M (−5.1%) vs. Q1 2025
- Total value
- $91.9M
- +$48.7M (+112.9%) vs. Q1 2025
- New holders
- 8
- 8 more added
- Sold out
- 19
- 10 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 59 | $0 | 0.00% | +4+7.3% | Added |
| Allworth Financial LP | 60 | $98 | 0.00% | +60 | New |
| SBI Securities Co., Ltd. | 400 | $648 | 0.00% | +267+200.8% | Added |
| Morgan Stanley | 503 | $815 | 0.00% | −34,938−98.6% | Reduced |
| Bank of America Corp | 610 | $989 | 0.00% | +50+8.9% | Added |
| NBC Securities, Inc. | 1,000 | $1.00K | 0.00% | +1,000 | New |
| BNP Paribas Arbitrage, SA | 1,017 | $1.65K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,295 | $3.72K | 0.00% | −1,153−33.4% | Reduced |
| MAI Capital Management | 3,652 | $5.92K | 0.00% | −284,711−98.7% | Reduced |
| JPMorgan Chase & Co | 8,997 | $14.6K | 0.00% | +7,138+384.0% | Added |
| Chicago Partners Investment Group LLC | 10,887 | $22.8K | 0.00% | −1,844−14.5% | Reduced |
| XTX Topco Ltd | 40,943 | $66.3K | 0.00% | +40,943 | New |
| DGS Capital Management, LLC | 55,300 | $89.6K | 0.02% | 00.0% | Unchanged |
| Bollard Group LLC | 55,555 | $90.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 72,417 | $117.3K | 0.00% | −74,605−50.7% | Reduced |
| Citigroup Inc | 87,485 | $141.7K | 0.00% | +87,485 | New |
| Trustees of Columbia University in the City of New York | 91,910 | $148.9K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 94,394 | $152.9K | 0.02% | +94,394 | New |
| State Street Corp | 115,934 | $187.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 169,636 | $274.8K | 0.00% | +46,645+37.9% | Added |
| Goldman Sachs Group Inc | 180,788 | $292.9K | 0.00% | +95,843+112.8% | Added |
| Virtu Financial LLC | 275,912 | $447.0K | 0.02% | +275,912 | New |
| BlackRock, Inc. | 374,763 | $607.1K | 0.00% | −109,743−22.7% | Reduced |
| Scientech Research LLC | 403,859 | $654.3K | 0.16% | +403,859 | New |
| Geode Capital Management, LLC | 435,560 | $705.8K | 0.00% | −2,450−0.6% | Reduced |
| Renaissance Technologies LLC | 468,112 | $758.3K | 0.00% | −233,319−33.3% | Reduced |
| HRT Financial LP | 474,575 | $768.0K | 0.00% | +474,575 | New |
| Sarissa Capital Management LP | 508,016 | $823.0K | 0.53% | 00.0% | Unchanged |
| Jane Street Group, LLC | 525,613 | $851.5K | 0.00% | +330,857+169.9% | Added |
| Johnson & Johnson | 1,074,658 | $1.14M | 0.34% | 00.0% | Unchanged |
| UBS Group AG | 1,531,636 | $2.48M | 0.00% | +1,523,181+18,015.2% | Added |
| Vanguard Group Inc | 1,915,606 | $3.10M | 0.00% | −24,617−1.3% | Reduced |
| FMR LLC | 2,092,686 | $3.39M | 0.00% | −4,329,810−67.4% | Reduced |
| 5AM Venture Management, LLC | 6,361,723 | $10.3M | 3.96% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 39,646,039 | $64.2M | 1.08% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −384,293−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −186,849−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −148,073−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −139,600−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −120,900−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −99,739−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −51,535−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −48,196−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −44,728−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −24,054−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −20,773−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −18,668−100.0% | Sold out |
| United Bank | 0 | $0 | 0.00% | −15,300−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −13,425−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −11,859−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −10,764−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,959−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,985−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −678−100.0% | Sold out |